期刊文献+

肝移植术后感染大肠埃希菌的DNA多态性与耐药性分析

Analyses of DNA Polymorphism and Drug Resistance of E.coli from Infected Patients after Liver Transplantation
下载PDF
导出
摘要 应用随机引物扩增多态性DNA(RAPD)技术分析肝移植术后大肠埃希菌感染株DNA的多态性,并对其进行分型,研究肝移植术后大肠埃希菌感染的流行状况,并探讨大肠埃希菌产超广谱β-内酰胺酶(ESBLs)与基因型之间的关系。应用1条含10个碱基的随机引物对20株大肠埃希菌的DNA进行随机扩增,ESBLs试验使用双纸片协同法。20株大肠埃希菌经RAPD分为11个基因型,ESBLs检测12株大肠埃希菌阳性,ESBLs阳性大肠埃希菌在700 bp有共同条带。肝移植术后感染以内源性感染为主,肠道细菌移位可能是大肠埃希菌感染的一个主要因素,ESBLs阳性检出率高,ESBLs阳性与基因型之间具有相关性。 Random primer of amplified polymorphism DNA (RAPD) technique was used to analyse the infection of E. coli infection strain and its typing after liver transplantation to study the epidemic conditions of the E. coli infection after the transplantation, and to investigate the relation between the production of super-broad spectrum β-1actamast (ESBLs) and genotype. A random primer containing 10 bases was used to amplify 20 strains of E. coli randomly. K-B method was used for determination of ESBLs. The results showed that 20 clinical infected strains of E. coli were RAPD classified into 11 types, and 12 strains were ESBLs positive, Therefore, the post-transplantation E. coli infection was mainly autogenously origin, and translocation of intestinal flora might play a major role. The incidence of ESBLs are high showing correlation with their genotyping.
出处 《微生物学杂志》 CAS CSCD 2006年第4期27-29,共3页 Journal of Microbiology
基金 湖南省卫生厅资助项目(B2004-067)
关键词 肝移植 大肠埃希菌 RAPD 基因分型 liver transplantation E. coli RAPD genotyping
  • 相关文献

参考文献4

二级参考文献27

  • 1陈规划,黄洁夫,何晓顺.原位肝移植术后巨细胞病毒感染[J].肝胆外科杂志,1995,3(3):174-175. 被引量:8
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S].9th informational supplement. Wayne, PA: NCCLS,1999.
  • 3Yagi T, Kurokawa H. A preliminary survey of extended-spectrum L-lactamases (ESBLs)in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan[J]. FEMS Microbiol Lett, 2000,184:54-55.
  • 4Knothe H, Shsh P, Kremery V, etal. Transferable to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens [J].Infection, 1983, 11:315.
  • 5NCCLS. Performance standards for antimicrobial susceptibility testing. Thirteenth informational supplement. NCCLS, 2003,100: 13.
  • 6Singh N. Infections diseases in the liver transplant recipient. Semin Gastrointest Dis, 1998, 9: 136-140.
  • 7Low DE, Keller N, Barth A, et al. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results form the Sentry Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis, 2001, 32:133-145.
  • 8汪复,吴溰,朱德妹.1998年上海地区细菌耐药性监测[J].中华内科杂志,1999,38(11):729-732. 被引量:133
  • 9张志萍,刘屏,秦庆芳,侯仁萍.抗菌药物消费趋势的药物经济学研究[J].中华医院感染学杂志,2000,10(1):64-65. 被引量:50
  • 10张嵘,金亚平.三种方法检测大肠埃希菌和肺炎克雷伯菌产超广谱β-内酰胺酶的研究[J].上海医学检验杂志,2000,15(2):96-98. 被引量:15

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部